| Developing a partnership to improve health care delivery to children< 18 years with cancer and blood disorders in the English-speaking Caribbean: lessons from the SickKids … M Reece-Mills, C Bodkyn, JAB Baxter, U Allen, C Alexis, ... The Lancet Regional Health–Americas 26, 2023 | 1 | 2023 |
| Sickle cell disease in the Caribbean: progress in newborn screening, clinical care, and research through collaboration J Knight-Madden, M Asnani, L King, MD Hardy-Dessources The Lancet Haematology 10 (8), e581-e582, 2023 | 1 | 2023 |
| Needs assessment in adults and parents of children living with sickle cell disease in Jamaica J Knight‐Madden, L King, M Asnani, N Skyers, C Lord, M Wright British Journal of Haematology, 2023 | | 2023 |
| Telehealth: Navigating the COVID-19 Pandemic and Beyond: The Sickle Cell Unit Experience L King, K Alexander-Gabbadon, N Chin, C Hammond-Gabbadon, ... Telemedicine and e-Health, 2023 | | 2023 |
| Factors Affecting Age of Initial Specialty Clinic Evaluation Among Infants with Sickle Cell Disease in Kingston, Jamaica J Knight-Madden, A Abar, M Smith, M Asnani The Journal of Pediatrics, 113384, 2023 | 1 | 2023 |
| Sickle Cell Disease Newborn Screening—An Audit of a Twin Island State Pilot Program S Belle Jarvis, E Hadeed, K Lee, MD Hardy-Dessources, ... International Journal of Neonatal Screening 9 (1), 14, 2023 | 1 | 2023 |
| P1453: STABLE TRANSDUCTION OF FETAL HEMOGLOBIN IN PATIENTS WITH SICKLE CELL DISEASE IN THE PHASE 1/2 MOMENTUM STUDY OF ARU-1801 GENE THERAPY AND REDUCED INTENSITY CONDITIONING M Grimley, M Kent, M Asnani, A Shrestha, S Felker, C Lutzko, ... HemaSphere 6, 1335-1336, 2022 | | 2022 |
| High Anti-Sickling Potency of a Gamma Globin in the Phase 1/2 MOMENTUM Study of ARU-1801 Gene Therapy and Reduced Intensity Conditioning for Sickle Cell Disease M Grimley, M Asnani, M Kent, A Shrestha, S Felker, C Lutzko, ... MOLECULAR THERAPY 30 (4), 25-26, 2022 | | 2022 |
| Vulnerable subpopulations in Caribbean children and adolescents hospitalized with COVID-19 T Evans-Gilbert, CS Quee, PM Lashley, J Knight-Madden, S Young-Peart, ... West Indian Medical Journal, 38-38, 2022 | | 2022 |
| Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease JM Knight-Madden, IR Hambleton Cochrane Database of Systematic Reviews, 2022 | 63 | 2022 |
| Multiethnic genome-wide and HLA association study of total serum IgE level M Daya, C Cox, N Acevedo, MP Boorgula, M Campbell, S Chavan, ... Journal of Allergy and Clinical Immunology 148 (6), 1589-1595, 2021 | 16 | 2021 |
| Safety and efficacy of Aru-1801 in patients with sickle cell disease: early results from the phase 1/2 momentum study of a modified gamma globin gene therapy and reduced … M Grimley, M Asnani, A Shrestha, S Felker, C Lutzko, PI Arumugam, ... Blood 138, 3970, 2021 | 16 | 2021 |
| Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler … A Rankine‐Mullings, M Reid, D Soares, C Taylor‐Bryan, ... British Journal of Haematology 195 (4), 612-620, 2021 | 14 | 2021 |
| Integrating a problem-solving intervention with routine care to improve psychosocial functioning among mothers of children with sickle cell disease: A randomized controlled trial MR Asnani, D Francis, J Knight-Madden, S Chang-Lopez, L King, ... Plos one 16 (6), e0252513, 2021 | 8 | 2021 |
| Early Results from a Phase 1/2 Study of ARU-1801 Gene Therapy for Sickle Cell Disease (SCD): Safety and Efficacy of a Modified Gamma Globin Lentivirus Vector and Reduced … M Grimley, M Asnani, A Shrestha, S Felker, C Lutzko, PI Arumugam, ... MOLECULAR THERAPY 29 (4), 39-40, 2021 | | 2021 |
| The impact of voxelotor treatment on leg ulcers in patients with sickle cell disease CP Minniti, J Knight‐Madden, M Tonda, S Gray, J Lehrer‐Graiwer, ... American Journal of Hematology 96 (4), E126, 2021 | 23 | 2021 |
| How free is free health care? An assessment of universal health coverage among Jamaicans with sickle cell disease ZJA Ramsay, RE Bartlett, CA Clarke, MR Asnani, JM Knight-Madden, ... Health equity 5 (1), 210-217, 2021 | 1 | 2021 |
| Use of the daycare ward for the management of acute complications of sickle cell disease in Jamaica: A retrospective review V Asnani, KM Black, J Harris, J Knight‐Madden, M Asnani International Journal of Clinical Practice 75 (1), e13755, 2021 | | 2021 |
| The risk of acute events among patients with sickle cell disease in relation to early or late initiation of care at a specialist center: evidence from a retrospective cohort study AE Rankine-Mullings, TM Logan, LG King, CA Cunningham-Myrie, ... BMC pediatrics 20 (1), 1-8, 2020 | 9 | 2020 |
| Early results from a phase 1/2 study of Aru-1801 gene therapy for sickle cell disease (SCD): manufacturing process enhancements improve efficacy of a modified gamma globin … M Grimley, M Asnani, A Shrestha, S Felker, C Lutzko, PI Arumugam, ... Blood 136, 20-21, 2020 | 17 | 2020 |
